Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease With Systemic Sclerosis”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableLooking for participantsNCT05345795
What this trial is testing

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 600
Large-scale testing (Phase 3)Study completedNCT00319033
What this trial is testing

Open-label Study With Bosentan in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseScleroderma
Actelion 132
Not applicableLooking for participantsNCT07345052
What this trial is testing

Western Sweden Systemic Sclerosis Project

Who this might be right for
Scleroderma, SystemicFibrosis; SkinFibrosis Lung+1 more
Sahlgrenska University Hospital 150
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Not applicableUnknownNCT06105073
What this trial is testing

"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung Disease
Coordinación de Investigación en Salud, Mexico 67
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Testing effectiveness (Phase 2)Ended earlyNCT00581997
What this trial is testing

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Who this might be right for
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals 8
Not applicableLooking for participantsNCT04095351
What this trial is testing

Connective Tissue Diseases and Lung Manifestations

Who this might be right for
Connective Tissue DiseasesInterstitial Lung DiseaseSystemic Sclerosis
Medical University Innsbruck 120
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Testing effectiveness (Phase 2)Study completedNCT03221257
What this trial is testing

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Who this might be right for
Scleroderma, SystemicInterstitial Lung Disease
Michael Roth 51
Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Testing effectiveness (Phase 2)Looking for participantsNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Not applicableActive Not RecruitingNCT07080125
What this trial is testing

A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

Who this might be right for
Interstitial Lung DiseasesSystemic Sclerosis Associated Interstitial Lung Disease
Boehringer Ingelheim 2,000
Not applicableUnknownNCT04650659
What this trial is testing

Functional Exercise Tests in Patients With Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more
University of Aarhus 83
Testing effectiveness (Phase 2)Looking for participantsNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Load More Results
30